Frequently Asked Questions about Mosaic ImmunoEngineering Inc. (CPMV)

Name: Mosaic ImmunoEngineering Inc. (CPMV) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Mosaic ImmunoEngineering Inc. (CPMV) do?

Accepted Answer

Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from...

Question 2

Is Mosaic ImmunoEngineering Inc. (CPMV) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of CPMV reveals an Altman Z-Score of -398.41 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if CPMV fits their risk profile.

Question 3

What is the current P/E ratio for CPMV?

Accepted Answer

As of the latest trading session, Mosaic ImmunoEngineering Inc. (CPMV) has a trailing P/E ratio of -8.03.

Question 4

Who is the CEO of Mosaic ImmunoEngineering Inc.?

Accepted Answer

The current Chief Executive Officer of Mosaic ImmunoEngineering Inc. is Steven W. King.

Question 5

What was CPMV's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Mosaic ImmunoEngineering Inc. reported annual revenues of $0.00B (2024), $0.00B (2022), $0.00B (2021), $0.00B (2020), $0.00B (2018) respectively.

Question 6

Does CPMV pay a dividend?

Accepted Answer

Mosaic ImmunoEngineering Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does CPMV have?

Accepted Answer

In its latest reporting period, Mosaic ImmunoEngineering Inc. generated $-0.00B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Mosaic ImmunoEngineering Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Mosaic ImmunoEngineering Inc. (CPMV) is currently -0.74.

Question 9

What is the Price-to-Sales (P/S) ratio of CPMV?

Accepted Answer

Based on trailing twelve-month data, Mosaic ImmunoEngineering Inc. (CPMV) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Mosaic ImmunoEngineering Inc.'s Return on Equity (ROE)?

Accepted Answer

Mosaic ImmunoEngineering Inc. (CPMV) has a Return on Equity (ROE) of 9.53%, representing its profitability relative to shareholder equity.